Rcm Technologies, Inc. RCMT
We take great care to ensure that the data presented and summarized in this overview for RCM TECHNOLOGIES, INC. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding RCMT
View all-
Jim Simons Renaissance Technologies LLC | New York, Ny531KShares$12.2 Million0.02% of portfolio
-
Morgan Stanley New York, NY402KShares$9.19 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA252KShares$5.78 Million0.0% of portfolio
-
Rutabaga Capital Management LLC210KShares$4.8 Million3.05% of portfolio
-
Dimensional Fund Advisors LP Austin, TX207KShares$4.74 Million0.0% of portfolio
-
Ballast Asset Management, LP Dallas, TX138KShares$3.17 Million1.44% of portfolio
-
Geode Capital Management, LLC Boston, MA65.1KShares$1.49 Million0.0% of portfolio
-
David A. Siegel Two Sigma Advisers, LP | New York, Ny62.5KShares$1.43 Million0.0% of portfolio
-
Black Rock Inc. New York, NY59.8KShares$1.37 Million0.0% of portfolio
-
Marshall Wace, LLP London, X057.7KShares$1.32 Million0.0% of portfolio
Latest Institutional Activity in RCMT
Top Purchases
Top Sells
About RCMT
RCM Technologies, Inc. provides business and technology solutions in the United States, Canada, Puerto Rico, and Serbia. It operates through three segments: Engineering, Specialty Health Care, and Life Sciences and Information Technology. The Engineering segment offers a range of engineering services, including project management engineering and design, engineering analysis, engineer-procure-construct, configuration management, hardware/software validation and verification, quality assurance, technical writing and publications, manufacturing process planning and improvement, and 3D/BIM integrated design. The Specialty Health Care segment provides long-term and short-term staffing, executive search, and placement services in the fields of allied and therapy staffing, correctional healthcare staffing, health information management, nursing services, physician and advanced practice, school services, and telepractice. The Life Sciences and Information Technology segment provides enterprise business solutions, application services, infrastructure solutions, competitive advantage, life sciences solutions, and other vertical market specific solutions. The company serves aerospace and defense, energy, financial services, health care, life sciences, manufacturing and distribution, and technology industries, as well as educational institutions and the public sector. RCM Technologies, Inc. was founded in 1971 and is based in Pennsauken, New Jersey.
Insider Transactions at RCMT
Insider Transaction List
View allDate | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Dec 12
2024
|
Swarna Srinivas Kakodkar Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,944
+3.32%
|
-
|
Dec 12
2024
|
Chigozie Obinna Amadi Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,944
+12.8%
|
-
|
Dec 12
2024
|
Jayanth Sree Komarneni Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,944
+3.07%
|
-
|
Dec 04
2024
|
Michael Saks Division President, HC Srvs. |
SELL
Open market or private sale
|
Direct |
2,852
-1.22%
|
$65,596
$23.98 P/Share
|
Dec 03
2024
|
Michael Saks Division President, HC Srvs. |
SELL
Open market or private sale
|
Direct |
2,148
-1.8%
|
$49,404
$23.5 P/Share
|
Dec 02
2024
|
Michael Saks Division President, HC Srvs. |
SELL
Open market or private sale
|
Direct |
5,000
-2.02%
|
$115,000
$23.21 P/Share
|
Jan 23
2024
|
Bradley Vizi Executive Chairman & President |
SELL
Payment of exercise price or tax liability
|
Direct |
24,594
-1.59%
|
$713,226
$29.99 P/Share
|
Jan 23
2024
|
Bradley Vizi Executive Chairman & President |
BUY
Grant, award, or other acquisition
|
Direct |
62,500
+3.89%
|
-
|
Jan 23
2024
|
Michael Saks Division President, HC Srvs. |
BUY
Grant, award, or other acquisition
|
Direct |
2,668
+2.11%
|
-
|
Jan 08
2024
|
Kevin D Miller CFO |
SELL
Open market or private sale
|
Direct |
1,400
-0.31%
|
$44,800
$32.0 P/Share
|
Jan 02
2024
|
Bradley Vizi Executive Chairman & President |
SELL
Payment of exercise price or tax liability
|
Direct |
19,973
-1.33%
|
$579,217
$29.04 P/Share
|
Dec 29
2023
|
Bradley Vizi Executive Chairman & President |
SELL
Open market or private sale
|
Direct |
848
-0.06%
|
$25,440
$30.01 P/Share
|
Dec 28
2023
|
Bradley Vizi Executive Chairman & President |
SELL
Open market or private sale
|
Direct |
2,325
-0.15%
|
$69,750
$30.0 P/Share
|
Dec 27
2023
|
Bradley Vizi Executive Chairman & President |
SELL
Open market or private sale
|
Direct |
18,474
-1.21%
|
$554,220
$30.01 P/Share
|
Dec 26
2023
|
Bradley Vizi Executive Chairman & President |
SELL
Open market or private sale
|
Direct |
13,003
-0.85%
|
$390,090
$30.0 P/Share
|
Dec 22
2023
|
Bradley Vizi Executive Chairman & President |
SELL
Open market or private sale
|
Direct |
11,862
-0.77%
|
$355,860
$30.01 P/Share
|
Dec 20
2023
|
Kevin D Miller CFO |
SELL
Open market or private sale
|
Direct |
13,442
-2.87%
|
$389,818
$29.01 P/Share
|
Dec 19
2023
|
Kevin D Miller CFO |
SELL
Open market or private sale
|
Direct |
26,558
-5.37%
|
$770,182
$29.02 P/Share
|
Dec 18
2023
|
Bradley Vizi Executive Chairman & President |
SELL
Open market or private sale
|
Direct |
11,200
-0.72%
|
$302,400
$27.59 P/Share
|
Dec 15
2023
|
Jayanth Sree Komarneni Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,695
+2.77%
|
-
|
Last 12 Months Summary
Grant, award, or other acquisition | 71K shares |
---|
Open market or private sale | 109K shares |
---|---|
Payment of exercise price or tax liability | 44.6K shares |